(Q39480163)

12 September 2017

title

Intravenous pamidronate disodium treatment of bone metastases in patients with breast cancer. A dose-seeking study (English)

1 reference

12 September 2017

4

Miller AA

1 reference

12 September 2017

D. Glover

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525038

18 May 2024

A. Lipton

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525038

18 May 2024

A. Keller

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525038

18 May 2024

S. Browning

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525038

18 May 2024

R. J. Fram

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525038

18 May 2024

S. George

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525038

18 May 2024

K. Zelenakas

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525038

18 May 2024

R. S. Macerata

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525038

18 May 2024

J. J. Seaman

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525038

18 May 2024

language of work or name

English

0 references

publication date

1 December 1994

1 reference

full work available at URL

12 September 2017

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1097-0142%2819941201%2974%3A11%3C2949%3A%3AAID-CNCR2820741110%3E3.0.CO%3B2-Q

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7525038

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19941201)74:11%3C2949::AID-CNCR2820741110%3E3.0.CO;2-Q

18 May 2024

1 reference

10.1002/1097-0142(19941201)74:11<2949::AID-CNCR2820741110>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2949::AID-CNCR2820741110%3E3.0.CO;2-Q

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19941201)74:11%3C2949::AID-CNCR2820741110%3E3.0.CO;2-Q

18 May 2024

1 reference

10.1002/1097-0142(19941201)74:11<2949::AID-CNCR2820741110>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2949::AID-CNCR2820741110%3E3.0.CO;2-Q

18 May 2024

1 reference

12 September 2017

volume

74

1 reference

12 September 2017

issue

11

1 reference

12 September 2017

page(s)

2949-2955

1 reference

Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819941201%2974%3A11%3C2949%3A%3AAID-CNCR2820741110%3E3.0.CO%3B2-Q

Bone metastases and breast cancer

21 January 2018

1

1 reference

10.1002/1097-0142(19941201)74:11<2949::AID-CNCR2820741110>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2949::AID-CNCR2820741110%3E3.0.CO;2-Q

Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chloride

18 May 2024

3

1 reference

10.1002/1097-0142(19941201)74:11<2949::AID-CNCR2820741110>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2949::AID-CNCR2820741110%3E3.0.CO;2-Q

Single dose versus daily intravenous aminohydroxypropylidene biphosphonate (APD) for the hypercalcaemia of malignancy

18 May 2024

4

1 reference

10.1002/1097-0142(19941201)74:11<2949::AID-CNCR2820741110>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2949::AID-CNCR2820741110%3E3.0.CO;2-Q

Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: comparison of 30-, 60-, and 90-mg dosages

18 May 2024

5

1 reference

10.1002/1097-0142(19941201)74:11<2949::AID-CNCR2820741110>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2949::AID-CNCR2820741110%3E3.0.CO;2-Q

A New Diphosphonate: Dissociation Between Effects on Cells and Mineral in Rats and a Preliminary Trial in Paget’s Disease

18 May 2024

6

1 reference

10.1002/1097-0142(19941201)74:11<2949::AID-CNCR2820741110>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2949::AID-CNCR2820741110%3E3.0.CO;2-Q

Kinetic studies of bone and mineral metabolism during treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) in rats

18 May 2024

7

1 reference

10.1002/1097-0142(19941201)74:11<2949::AID-CNCR2820741110>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2949::AID-CNCR2820741110%3E3.0.CO;2-Q

Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat.

18 May 2024

8

1 reference

10.1002/1097-0142(19941201)74:11<2949::AID-CNCR2820741110>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2949::AID-CNCR2820741110%3E3.0.CO;2-Q

Inhibition of osteolytic bone lesions by (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.)

18 May 2024

9

1 reference

10.1002/1097-0142(19941201)74:11<2949::AID-CNCR2820741110>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2949::AID-CNCR2820741110%3E3.0.CO;2-Q

Treatment of bone metastases from breast cancer and myeloma with pamidronate.

18 May 2024

10

1 reference

10.1002/1097-0142(19941201)74:11<2949::AID-CNCR2820741110>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2949::AID-CNCR2820741110%3E3.0.CO;2-Q

Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma

18 May 2024

12

1 reference

10.1002/1097-0142(19941201)74:11<2949::AID-CNCR2820741110>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2949::AID-CNCR2820741110%3E3.0.CO;2-Q

The palliation of symptomatic osseous metastases: final results of the Study by the Radiation Therapy Oncology Group

18 May 2024

13

1 reference

10.1002/1097-0142(19941201)74:11<2949::AID-CNCR2820741110>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2949::AID-CNCR2820741110%3E3.0.CO;2-Q

Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandins

18 May 2024

14

1 reference

10.1002/1097-0142(19941201)74:11<2949::AID-CNCR2820741110>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2949::AID-CNCR2820741110%3E3.0.CO;2-Q

Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment

18 May 2024

16

1 reference

10.1002/1097-0142(19941201)74:11<2949::AID-CNCR2820741110>3.0.CO;2-Q

https://api.crossref.org/works/10.1002/1097-0142(19941201)74:11%3C2949::AID-CNCR2820741110%3E3.0.CO;2-Q

18 May 2024

Identifiers

10.1002/1097-0142(19941201)74:11<2949::AID-CNCR2820741110>3.0.CO;2-Q

1 reference

12 September 2017

1 reference